1. Home
  2. AMBO vs XBIO Comparison

AMBO vs XBIO Comparison

Compare AMBO & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambow Education Holding Ltd.

AMBO

Ambow Education Holding Ltd.

BUY

Current Price

$1.83

Market Cap

5.9M

Sector

Real Estate

ML Signal

BUY

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

HOLD

Current Price

$2.20

Market Cap

5.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMBO
XBIO
Founded
2000
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9M
5.8M
IPO Year
2010
2011

Fundamental Metrics

Financial Performance
Metric
AMBO
XBIO
Price
$1.83
$2.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.7K
★ 99.8K
Earning Date
11-11-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 337.04
38.52
EPS
★ 0.00
N/A
Revenue
★ $9,469,000.00
$2,976,411.00
Revenue This Year
N/A
$2.37
Revenue Next Year
N/A
N/A
P/E Ratio
$379.59
★ N/A
Revenue Growth
0.82
★ 19.04
52 Week Low
$1.47
$1.90
52 Week High
$6.75
$13.93

Technical Indicators

Market Signals
Indicator
AMBO
XBIO
Relative Strength Index (RSI) 36.20 34.54
Support Level $1.69 $2.14
Resistance Level $2.31 $2.62
Average True Range (ATR) 0.07 0.28
MACD -0.02 -0.10
Stochastic Oscillator 0.00 2.65

Price Performance

Historical Comparison
AMBO
XBIO

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.

Share on Social Networks: